Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinu Abraham

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Biorxiv : the Preprint Server for Biology|August 12, 2025
Characterization of a Novel Transmembrane Activating STING Agonist using Genetically Humanized MiceNobuyo Mizuno, Jinu Abraham, Kevin Jimenez-Perez, et al.
Cell Reports|June 2, 2026
Characterization of a transmembrane-activating STING agonist using genetically humanized miceNobuyo Mizuno, Jinu Abraham, Kevin Jimenez-Perez, et al.
Biochemical and Biophysical Research Communications|September 11, 2012
An adaptive Src-PDGFRA-Raf axis in rhabdomyosarcomaJinu Abraham, Ying Xuan Chua, Jason M Glover, et al.
Mbio|May 4, 2017
A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue VirusesKara M Pryke, Jinu Abraham, Tina M Sali, et al.
Skeletal Muscle|November 27, 2013
Rb1 loss modifies but does not initiate alveolar rhabdomyosarcomaKen Kikuchi, Eri Taniguchi, Hung-I Harry Chen, et al.
Cancer Cell|February 15, 2011
Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcomaBrian P Rubin, Koichi Nishijo, Hung-I Harry Chen, et al.
Scientific Reports|June 4, 2016
IGF1R as a Key Target in High Risk, Metastatic MedulloblastomaMatthew N Svalina, Ken Kikuchi, Jinu Abraham, et al.
Skeletal Muscle|May 23, 2019
Preclinical rationale for entinostat in embryonal rhabdomyosarcomaNarendra Bharathy, Noah E Berlow, Eric Wang, et al.
BMC Cancer|June 19, 2019
Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcomaNoah E Berlow, Rishi Rikhi, Mathew Geltzeiler, et al.
Genes & Development|July 18, 2014
Lineage of origin in rhabdomyosarcoma informs pharmacological responseJinu Abraham, Yaiza Nuñez-Álvarez, Simone Hettmer, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Biorxiv : the Preprint Server for Biology|August 12, 2025
Characterization of a Novel Transmembrane Activating STING Agonist using Genetically Humanized MiceNobuyo Mizuno, Jinu Abraham, Kevin Jimenez-Perez, et al.
Cell Reports|June 2, 2026
Characterization of a transmembrane-activating STING agonist using genetically humanized miceNobuyo Mizuno, Jinu Abraham, Kevin Jimenez-Perez, et al.
Biochemical and Biophysical Research Communications|September 11, 2012
An adaptive Src-PDGFRA-Raf axis in rhabdomyosarcomaJinu Abraham, Ying Xuan Chua, Jason M Glover, et al.
Mbio|May 4, 2017
A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue VirusesKara M Pryke, Jinu Abraham, Tina M Sali, et al.
Skeletal Muscle|November 27, 2013
Rb1 loss modifies but does not initiate alveolar rhabdomyosarcomaKen Kikuchi, Eri Taniguchi, Hung-I Harry Chen, et al.
Cancer Cell|February 15, 2011
Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcomaBrian P Rubin, Koichi Nishijo, Hung-I Harry Chen, et al.
Scientific Reports|June 4, 2016
IGF1R as a Key Target in High Risk, Metastatic MedulloblastomaMatthew N Svalina, Ken Kikuchi, Jinu Abraham, et al.
Skeletal Muscle|May 23, 2019
Preclinical rationale for entinostat in embryonal rhabdomyosarcomaNarendra Bharathy, Noah E Berlow, Eric Wang, et al.
BMC Cancer|June 19, 2019
Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcomaNoah E Berlow, Rishi Rikhi, Mathew Geltzeiler, et al.
Genes & Development|July 18, 2014
Lineage of origin in rhabdomyosarcoma informs pharmacological responseJinu Abraham, Yaiza Nuñez-Álvarez, Simone Hettmer, et al.
Pageof 4